The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The Risk of Stroke in Patients with Psoriasis
Open accessAbstract
Psoriasis is a chronic Th-1 and Th-17 inflammatory disease. Chronic inflammation has also been associated with atherosclerosis and thrombosis. The purpose of this study was to determine the risk of stroke in patients with psoriasis. We conducted a population-based cohort study of patients seen by general practitioners participating in the General Practice Research Database in the United Kingdom 1987-2002. Mild psoriasis was defined as any patient with a diagnostic code of psoriasis but no history of systemic therapy. Severe psoriasis was defined as any patient with a diagnostic code of psoriasis and a history of systemic therapy consistent with severe psoriasis. The unexposed (control) population was composed of patients with no history of a psoriasis diagnostic code. When adjusting for major risk factors for stroke, both mild (HR 1.06, 95% CI 1.0-1.1) and severe (1.43, 95% CI 1.1, 1.9) psoriasis were independent risk factors for stroke. The excess risk of stroke attributable to psoriasis in patients with mild and severe disease was 1 in 4115 per year and 1 in 530 per year, respectively. Patients with psoriasis, particularly if severe, have an increased risk of stroke that is not explained by major stroke risk factors identified in routine medical care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“For example, Th-1 chronic inflammation characteristic of the psoriasis phenotype is also central to the pathophysiology of other conditions, such as insulin resistance, atherosclerosis, and plaque rupture, leading to thrombotic events (Hirosumi et al ., 2002; Hansson, 2005).”
BackgroundDonnan, G. A., Fisher, M., Macleod, M., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,218
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899 · cited 3×
“The GPRD has also been studied in numerous validation studies, including those of psoriasis and cardiovascular disease, to show that it captures these outcomes accurately (Gelfand et al ., 2003, 2005a, 2005b; Neimann et al ., 2006; Huerta et al ., 2007).”
BackgroundSelf-citationPrevalence of cardiovascular risk factors in patients with psoriasis
Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.040 · Cited by 1,010
Self-citationAlcohol Consumption and Risk of Stroke: A Meta-analysis
Reynolds, K., Lewis, B., Nolen, J. D. L., Kinney, G. L., Sathya, B., & He, J. (2003) · JAMA · doi:10.1001/jama.289.5.579 · Cited by 916
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Prevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study
Gelfand, J. M., Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., & Margolis, D. J. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1537 · Cited by 600
Self-citation
Cited by
Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E., & Barker, J. N. W. N. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32549-6 · Cited by 2,383
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review
Armstrong, A. W., & Read, C. (2020) · JAMA · doi:10.1001/jama.2020.4006 · Cited by 2,335
Psoriasis Pathogenesis and Treatment
Rendon, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,064
Psoriasis prevalence among adults in the United States
Rachakonda, T. D., Schupp, C. W., & Armstrong, A. W. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.013 · Cited by 783
Mehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706
Self-citationLangan, S. M., Seminara, N. M., Shin, D. B., Troxel, A. B., Kimmel, S. E., Mehta, N. N., Margolis, D. J., & Gelfand, J. M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.365 · Cited by 525
Self-citationElmets, C. A., Leonardi, C. L., Davis, D. M. R., Gelfand, J. M., Lichten, J., Mehta, N. N., Armstrong, A. W., Connor, C., Cordoro, K. M., Elewski, B. E., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.058 · Cited by 503
Self-citationOgdie, A., Yu, Y., Haynes, K., Love, T. J., Maliha, S., Jiang, Y., Troxel, A. B., Hennessy, S., Kimmel, S. E., Margolis, D. J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205675 · Cited by 490
Self-citationAbuabara, K., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09941.x · Cited by 472
Self-citationArmstrong, E. J., Harskamp, C. T., & Armstrong, A. W. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000062 · Cited by 470
Psoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study
Yeung, H., Takeshita, J., Mehta, N. N., Kimmel, S. E., Ogdie, A., Margolis, D. J., Shin, D. B., Attor, R., Troxel, A. B., & Gelfand, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5015 · Cited by 464
Self-citationAhlehoff, O., Gislason, G. H., Charlot, M., Jørgensen, C. H., Lindhardsen, J., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02310.x · Cited by 441
Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
Mehta, N. N., Yu, Y., Pinnelas, R., Krishnamoorthy, P., Shin, D. B., Troxel, A. B., & Gelfand, J. M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.03.028 · Cited by 345
Self-citationCo-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany
Augustin, M., Reich, K., Glaeske, G., Schaefer, I., & Radtke, M. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0770 · Cited by 337
Horreau, C., Pouplard, C., Brenaut, E., Barnetche, T., Misery, L., Cribier, B., Jullien, D., Aractingi, S., Aubin, F., Joly, P., et al. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12163 · Cited by 313
Wu, J. J., Poon, K.-Y. T., Channual, J. C., & Shen, A. Y.-J. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.2502 · Cited by 304
Samarasekera, E. J., Neilson, J. M., Warren, R. B., Parnham, J., & Smith, C. H. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.149 · Cited by 298
Machine learning applications in the evaluation and management of psoriasis: a systematic review
Yu, K., Syed, M. N., Bernardis, E., & Gelfand, J. M. (2020) · Journal of Psoriasis and Psoriatic Arthritis · doi:10.1177/2475530320950267 · Cited by 65
Self-citationTranscriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis
Varshney, P., Narasimhan, A., Mittal, S., Malik, G., Sardana, K., & Saini, N. (2016) · Scientific Reports · doi:10.1038/srep19295 · Cited by 64
Shaaban, D., & Al-Mutairi, N. (2018) · Journal of Dermatological Treatment · doi:10.1080/09546634.2016.1254145 · Cited by 18
Metadata
- Authors
- Gelfand, J. M., Dommasch, E. D., Shin, D. B., Azfar, R. S., Kurd, S. K., Wang, X., & Troxel, A. B.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 129
- Issue
- 10
- Pages
- 2411-2418
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2028621745
- Cited by
- 439
- References
- 37
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.